Serveur d'exploration sur l'Indium - Curation (Accueil)

Index « MedMesh.i » - entrée « Liposomes »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Liposarcoma < Liposomes < Lipoxygenase Inhibitors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 104.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000253 (2014) Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging.
000447 (2013) Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.
000900 (2012) Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
000E82 (2012) Correlation between radioactivity and chemotherapeutics of the (111)In-VNB-liposome in pharmacokinetics and biodistribution in rats.
001325 (2011) Preparation and dynamic patterning of supported lipid membranes mimicking cell membranes.
001346 (2012) Targeting properties of peptide-modified radiolabeled liposomal nanoparticles.
001603 (2011) The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma.
001945 (2010) Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
001A88 (2010) Multifunctional radionanomedicine: a novel nanoplatform for cancer imaging and therapy.
001C02 (2009) Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.
001C40 (2010) Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals.
001C73 (2009) Analysis of interaction between liposome membranes induced by stress condition: utilization of liposomes immobilized on indium tin oxide electrode.
001D30 (2009) Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model.
001E13 (2009) Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
002009 (2009) Formation of supported lipid bilayers on indium tin oxide for dynamically-patterned membrane-functionalized microelectrode arrays.
002321 (2008) Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model.
002472 (2008) Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice.
002759 (2007) Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.
002946 (2007) Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis.
002A29 (????) Enhanced tumor visualization by gamma-scintigraphy with 111In-labeled polychelating-polymer-containing immunoliposomes.
002B41 (2006) Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Liposomes" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Liposomes" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Liposomes
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024